4.8 Article

Dendritic cells with TGF-β1 differentiate naive CD4+CD25- T cells into islet-protective Foxp3+ regulatory T cells

出版社

NATL ACAD SCIENCES
DOI: 10.1073/pnas.0611646104

关键词

antigen-presenting cells; autoimmunity; type 1 diabetes; nonobese diabetic (NOD) mice

资金

  1. NIAID NIH HHS [AI 51573, P01 AI051573] Funding Source: Medline
  2. NIDDK NIH HHS [5K01 DK 071586-02, K08 DK070029, 1K08 DK 070029-01, K01 DK071586, R21 DK 60186] Funding Source: Medline

向作者/读者索取更多资源

CD4(+)CD25(+)Foxp3(+) regulatory T cells (T regs) are important for preventing autoimmune diabetes and are either thymic-derived (natural) or differentiated in the periphery outside the thymus (induced). Here we show that beta-cell peptide-pulsed dendritic cells (DCs) from nonobese diabetic (NOD) mice can effectively induce CD4(+)CD25(+)Foxp3(+) T cells from naive islet-specific CD4(+)CD25(-) T cells in the presence of TGF-beta 1. These induced, antigen-specific T regs maintain high levels of clonotype-specific T cell receptor expression and exert islet-specific suppression in vitro. When cotransferred with diabetogenic cells into NOD scid recipients, T regs induced with DCs and TGF-beta 1 prevent the development of diabetes. Furthermore, in overtly NOD mice, these cells are able to significantly protect syngeneic islet grafts from established destructive autoimmunity. These results indicate a role for DCs in the induction of antigen-specific CD4(+)CD25(+)Foxp3(+) T cells that can inhibit fully developed autoimmunity in a nonlymphopoenic host, providing an important potential strategy for immunotherapy in patients with autoimmune diabetes.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.8
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据